Serum calcitonin gene-related peptide facilitates adipose tissue lipolysis during exercise via PIPLC/IP3 pathways
- 188 Downloads
Calcitonin gene-related peptide (CGRP) is formed by alternative transcription of the calcitonin/α-CGRP gene, which also gives rise to calcitonin (CT). Recently, CGRP has been the focus of research for its metabolic effects in vitro. In the present study, the in vivo effects of CGRP on epididymal fat pads lipolysis at rest and during exercise were investigated in trained male Wistar rats.
Male Wistar rats were assigned to control and trained groups, which underwent endurance training for 12 weeks. The control (at rest) and trained (during acute exercise) animals were subjected to an intravenous injection of rat recombinant CGRP (2 µg kg−1) and CGRP-(8–37), a competitive CGRP receptors antagonist, to evaluate if and how CGRP can affect adipose tissue lipolysis at rest and during exercise.
Intravenous injection of rat CGRP recombinant at rest upregulated major lipolysis pathways (cyclic AMP (cAMP), AMP-activated protein kinase (AMPK), and phospholipase C (PIPLC/IP3)) in fat pads, causing an elevation in plasma-free fatty acid (FFA) and a decrease in plasma triglyceride (TG). All the effects were eliminated by pretreating the animals with CGRP-(8–37), suggesting that CGRP receptors were necessary for lipolytic effects of CGRP in fat pads. In trained animals, acute exercise augmented CGRP in serum, cerebrospinal fluid (CSF), and the cortex. Pretreating the animals with CGRP-(8–37) attenuated PIPLC/IP3 pathway in fat pads and had no effect on cAMP and AMPK pathways.
Epididymal fat pads is a metabolic target for CGRP during exercise and CGRP effects on adipose tissue metabolism during exercise could be related to PIPLC/IP3 pathway.
KeywordsCalcitonin gene-related peptide Endurance training Epididymal fat lipolysis Neuropeptides
We gratefully acknowledge Kerman Neuroscience Research Center and all our collaborators.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 12.M. Meens, N. Mattheij, P. van Loenen, L. Spijkers, P. Lemkens, J. Nelissen, M. Compeer, A. Alewijnse, J. De Mey, G‐protein βγ subunits in vasorelaxing and anti‐endothelinergic effects of calcitonin gene‐related peptide. Br. J. Pharmacol. 166(1), 297–308 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
- 14.S.-J. Smillie, R. King, X. Kodji, E. Outzen, G. Pozsgai, E. Fernandes, N. Marshall, P. De Winter, R.J. Heads, C. Dessapt-Baradez, An ongoing role of α-calcitonin gene–related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress. Hypertension 63(5), 1056–1062 (2014)CrossRefPubMedGoogle Scholar
- 16.R.N. Danaher, K.M. Loomes, B.L. Leonard, L. Whiting, D.L. Hay, L.Y. Xu, E.W. Kraegen, A.R. Phillips, G.J. Cooper, Evidence that α-calcitonin gene-related peptide is a neurohormone that controls systemic lipid availability and utilization. Endocrinology 149(1), 154–160 (2008)CrossRefPubMedGoogle Scholar
- 20.K. Chatzipanteli, R.B. Goldbergt, G.A. Howard, B.A. Roos, Calcitonin gene-related peptide is an adipose-tissue neuropeptide with lipolytic actions. Endocrinol. Metab. 3(4), 235–242 (1996)Google Scholar
- 30.M. Mansouri, R. Nikooie, A. Keshtkar, B. Larijani, K. Omidfar, Effect of endurance training on retinol‐binding protein 4 gene expression and its protein level in adipose tissue and the liver in diabetic rats induced by a high‐fat diet and streptozotocin. J. Diabetes Investig. 5(5), 484–491 (2014)CrossRefPubMedPubMedCentralGoogle Scholar
- 33.M.A. Patestas, L.P. Gartner. A Textbook of Neuroanatomy John Wiley & Sons, New Jersey (2016)Google Scholar
- 50.R.J. Ho , Dependence of hormone-stimulated lipolysis on ATP and cyclic AMP levels in fat cells. Horm Metab Res 2 (Suppl 2), 83–87 (1970).Google Scholar
- 51.G. Robison, R. Butcher, E. Sutherland, in Cyclic AMP. Academic Press: New York. (1971) pp. 286–316Google Scholar